Back to MW MARSHALL WACE, LLP
CRL31 quarters
Position history for MWMARSHALL WACE, LLP's holdings in CHARLES RIVER LABORATORIES
MARSHALL WACE, LLP holds 342,995 shares of CRL (CHARLES RIVER LABORATORIES), worth $77.8M as of 2026-Q2. The position was increased (+129.2% shares). CRL represents 0.1% of MARSHALL WACE, LLP's portfolio.
Current Value
$77.8M
Current Shares
342,995
Total Value Change
+$77.3M
Total Shares Change
+338,925
Quarter-by-Quarter History
Other major holders of CRL: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., VANGUARD GROUP INC